Preferred Label : Rocuronium;
MeSH definition : An androstanol non-depolarizing neuromuscular blocking agent. It has a mono-quarternary
structure and is a weaker nicotinic antagonist than PANCURONIUM.; An androstanol non-depolarizing neuromuscular blocking agent. It has a mono-quaternary
structure and is a weaker nicotinic antagonist than PANCURONIUM.;
MeSH synonym : 1-(17-(Acetoyl)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)pyrrolidinium; Androstane-3,17-diol, 2-(4-morpholinyl)-16-(1-(2-propen-1-yl)-1-pyrrolidiniumyl)-,
17-acetate, (2beta,3alpha,5alpha,16beta,17beta)-;
MeSH hyponym : ORG9426; ORG 9426; Esmerone; Pyrrolidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-,
bromide;
MeSH CAS label : Androstane-3,17-diol, 2-(4-morpholinyl)-16-(1-(2-propen-1-yl)-1-pyrrolidiniumyl)-,
17-acetate, (2beta,3alpha,5alpha,16beta,17beta)-;
MeSH Related Number : I65MW4OFHZ;
UNII : WRE554RFEZ;
Origin ID : D000077123;
UMLS CUI : C0209337;
ATC code(s)
Allowable qualifiers
Pharmacological action(s)
Record concept(s)
Semantic type(s)
An androstanol non-depolarizing neuromuscular blocking agent. It has a mono-quarternary
structure and is a weaker nicotinic antagonist than PANCURONIUM.
An androstanol non-depolarizing neuromuscular blocking agent. It has a mono-quaternary
structure and is a weaker nicotinic antagonist than PANCURONIUM.
https://www.has-sante.fr/jcms/p_3526087/fr/rocuronium-aguettant-bromure-de-rocuronium-anesthesie
2024
false
false
false
France
insurance, health, reimbursement
Pre-filled Syringe
Product containing precisely rocuronium bromide 10 milligram/1 milliliter conventional
release solution for injection (clinical drug)
injections, intravenous
neuromuscular nondepolarizing agents
rocuronium bromide
adjuvants, anesthesia
intubation, intratracheal
evaluation of the transparency committee
Rocuronium
anesthesia, general
rocuronium bromide
---
https://www.has-sante.fr/portail/jcms/c_2964136/fr/rocuronium-hikma
2019
false
false
false
France
drugs, generic
evaluation of the transparency committee
Rocuronium
---
https://www.has-sante.fr/portail/jcms/c_2963352/fr/rocuronium-kalceks
2019
false
true
false
false
France
French
evaluation of the transparency committee
rocuronium bromide
Rocuronium
Adjuvant therapy
neuromuscular agents
anesthesia, general
Rocuronium
---
https://www.has-sante.fr/portail/jcms/c_2888471/fr/rocuronium-mylan
2018
false
false
false
France
evaluation of the transparency committee
androstanols
Rocuronium
---
Summary Basis of Decision (SBD) for Bridion
Sugammadex sodium, 100 mg/mL, solution, intravenous
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00283
2016
false
false
false
Canada
French
English
summary of product characteristics
Sugammadex sodium
Sugammadex sodium
injections, intravenous
sugammadex
vecuronium bromide
neuromuscular nondepolarizing agents
anesthesia recovery period
Neuromuscular blockade reversal
adult
risk assessment
neuromuscular blockade
gamma-cyclodextrins
gamma-cyclodextrins
androstanols
Sugammadex
Sugammadex
Rocuronium
---
http://www.has-sante.fr/portail/jcms/c_2032514/fr/rocuronium-b-braun
2015
false
false
false
France
French
evaluation of the transparency committee
Organisms Category
androstanols
Rocuronium
---
http://www.has-sante.fr/portail/jcms/c_2045293/fr/rocuronium-hospira
2015
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
rocuronium bromide
androstanols
Rocuronium
---
http://www.has-sante.fr/portail/jcms/c_1743365/fr/rocuronium-pfizer
2014
false
false
false
France
evaluation of the transparency committee
androstanols
Rocuronium
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64544979
2012
France
summary of product characteristics
package leaflet
injections
bromides
rocuronium bromide
Rocuronium
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65047019
2012
France
summary of product characteristics
package leaflet
bromides
rocuronium bromide
Rocuronium
---
https://www.ema.europa.eu/medicines/human/EPAR/Bridion
2012
United Kingdom
French
English
syndication feed
gamma-cyclodextrins
gamma-cyclodextrins
antidotes
drug approval
drug labeling
treatment outcome
injections, intravenous
adult
child
adolescent
vecuronium bromide
neuromuscular nondepolarizing agents
androstanols
anesthesia recovery period
respiratory muscles
neuromuscular blockade
aged
monitoring, physiologic
drug interactions
breast feeding
drug evaluation, preclinical
antidotes
pregnancy
drug incompatibility
drug storage
drug compounding
sugammadex
androstanols
gamma-cyclodextrins
package leaflet
drug evaluation
summary of product characteristics
Sugammadex
Sugammadex
Rocuronium
---